Synovial Fluid Analysis #synovial #fluid #analysis, # #2006 #21st #abnormal #abnormally #activities


#

Synovial Fluid Analysis

Synovial fluid analysis is a group of tests that examine joint (synovial) fluid. The tests help diagnose and treat joint-related problems.

Alternative Names

Joint fluid analysis; Joint fluid aspiration

How the test is performed

A sample of synovial fluid is needed for this test. Synovial fluid is normally a thick, straw-colored liquid found in small amounts in joints, bursae, and tendon sheaths.

After the area is cleaned, the health care provider will insert a sterile needle through the skin and into the joint space. Once in the joint, fluid is drawn through the needle into a sterile syringe.

The fluid sample is sent to the laboratory. The laboratory technician will check the sample’s color and clarity, and then place it under a microscope to check it for red and white blood cells, crystals (in the case of gout), and bacteria. In addition, there may be a chemical analysis, and if infection is a concern, a sample will be cultured to see if any bacteria grow.

How to prepare for the test

Normally, no special preparation is necessary, but contact your health care provider before the test to make sure. Tell your doctor if you are taking blood thinners, as they can affect test results.

How the test will feel

Occasionally, the health care provider will first inject local anesthesia with a small needle, which will sting. The aspiration is done with a larger needle and may also cause some pain. The procedure usually lasts less than one minute.

Why the test is performed

The test can help diagnose the cause of pain or swelling in joints. Removing the fluid can also help relieve joint pain.

This test may be used to diagnose:

  • Gout
  • Infection
  • Other inflammatory joint conditions
  • Joint injury
  • Osteoarthritis

What abnormal results mean

Abnormal joint fluid may look cloudy or abnormally thick.

Blood in the joint fluid may be a sign of injury inside the joint or a body-wide bleeding problem. An excess amount of normal synovial fluid can also be a sign of osteoarthritis.

What the risks are

  • Infection of the joint — unusual but more common with repeated aspirations
  • Bleeding into the joint space

Special considerations

Ice or cold packs may be applied to the joint for 24 to 36 hours after the test to reduce the swelling and joint pain. Depending on the exact problem, you can probably resume your normal activities after the procedure. Talk to your health care provider to determine what activity is most appropriate for you.

References

Knight JA, Kjeldsberg CR. Cerebrospinal, synovial, and serous body fluids. In: McPherson RA, Pincus MR, eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 21st ed. Philadelphia, Pa: Saunders Elsevier; 2006:chap 28.

Review Date: 7/10/2009

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsements of those other sites. Copyright 2010 A.D.A.M. Inc. as modified by University of California San Francisco. Any duplication or distribution of the information contained herein is strictly prohibited.

Information developed by A.D.A.M. Inc. regarding tests and test results may not directly correspond with information provided by UCSF Medical Center. Please discuss with your doctor any questions or concerns you may have.

Getting Care


First Plasma in New Reactor Brings the UK a Big Step Closer


#

First Plasma in New Reactor Brings the UK a Big Step Closer to Fusion Energy (Tokamak Energy Press Release)

First plasma in new reactor brings the UK a big step closer to fusion energy

+ Tokamak Energy turns on the ST40, it’s third reactor in five years +

+ The reactor will reach 100m degrees in 2018, the temperature required for fusion +

+ ST40 is the third stage of a five stage plan that will deliver fusion energy into the grid by 2030 +

The UK’s newest fusion reactor has been turned on for the first time and has officially achieved first plasma. The reactor aims to produce a record-breaking plasma temperature of 100 million degrees for a privately-funded venture. This is seven times hotter than the centre of the Sun and the temperature necessary for controlled fusion.

The tokamak reactor, entitled the ‘ST40’, was built by Tokamak Energy, one of the world’s leading private fusion energy ventures. The Oxfordshire-based company grew out of the Culham Centre for Fusion Energy and was established in 2009 to design and develop small fusion reactors. Tokamak Energy’s aim is to put fusion power into the grid by 2030.

With the ST40 up and running, the next steps are to complete the commissioning and installation of the full set of magnetic coils which are crucial to reaching the temperatures required for fusion. This will allow the ST40 to a produce plasma temperature of 15 million degrees – as hot as the centre of the Sun – in Autumn 2017.

Following the 15 million degree milestone, the next goal is for the ST40 to produce plasma temperatures of 100 million degrees in 2018. This will be a record-breaking milestone, as the plasma will reach a temperature never before achieved in a privately owned and funded fusion reactor. 100 million degrees is an important threshold, as it is only at or above this temperature that charged particles which naturally repel can be forced together to induce the controlled fusion reaction. It will also prove the vital point that commercially viable fusion power can be produced in compact spherical tokamaks.

Tokamak Energy’s journey to generating fusion energy is moving at a rapid pace; the company has already reached the half-way point of its plan to deliver fusion power. It is focused on working with a smaller reactor design – called a compact, spherical tokamak – that enables quicker development of devices, therefore speeding up the process towards achieving their ultimate targets: producing first electricity by 2025 and commercially viable fusion power by 2030. Tokamak Energy’s research has also proven that this route to fusion power can be much faster than the development of conventional large-scale tokamak devices.

Dr David Kingham, CEO of Tokamak Energy, commented: “Today is an important day for fusion energy development in the UK, and the world. We are unveiling the first world-class controlled fusion device to have been designed, built and operated by a private venture. The ST40 is a machine that will show fusion temperatures – 100 million degrees – are possible in compact, cost-effective reactors. This will allow fusion power to be achieved in years, not decades.”

“We will still need significant investment, many academic and industrial collaborations, dedicated and creative engineers and scientists, and an excellent supply chain. Our approach continues to be to break the journey down into a series of engineering challenges, raising additional investment on reaching each new milestone. We are already half-way to the goal of fusion energy; with hard work we will deliver fusion power at commercial scale by 2030.”

For further information, please contact:

David Cohen, Senior Account Manager, AprilSix Proof

07729 321096 / 020 3141 2973


Teen Drug Abuse: Cough Medicine and DXM (Dextromethorphan) #dxm #abuse, #pure #dxm,


#

Next Article:

Skip to Article Content

  • 9 Warning Signs of Teen Drug Abuse Would you know if your teen was abusing cough and cold medicine?
  • Hiding Drugs in Plain Sight DXM is in almost every home. Are you tempting your teen?
  • Checklist: How to Help Your Teen Hands-on advice about how to help protect your teen from drugs.
  • The Rise in Cough Medicine Abuse It’s cheap, easy to get — and very dangerous.
  • One Girl’s Story of Addiction Kristin was just 15 when she first tried getting high on cough medicine.
  • A Mother’s Struggle She says she should have seen the signs. She had no idea her daughter was in trouble.
  • How Kids Get Hooked They say, “What’s the big deal? It’s only cough syrup!”
  • Teens Take a Stand The truth? Most teens don’t use drugs. These tips can help teens take a stand.
  • Making the Right Decisions Check out these common situations. How would you react?
  • Role Playing for Teens and Parents Read over these scenarios together. Act them out with your teen.
  • Tips on Teachable Moments Your teen needs more than a single “talk” about drugs.
  • Common Drug Slang Have you heard these words? Get to know drug slang to help protect your child.
  • 5 Teen Behavior Problems Does your teen defy you a lot? Here’s how to nip behavior problems in the bud.
  • Teens and Peer Pressure Friends play a subtle role in your child’s decisions.
  • When Teens Lie About Drugs It’s a fact: Teens lie about drugs — and too often parents believe them.
  • Teen Depression: Symptoms and Tips Many teens are irritable or moody. How can you tell when it’s really depression?
  • 5 Mistakes Parents Make The top mistakes parents make with tweens and teens — and how to avoid them.
  • Monitoring Your Teen Online Should you monitor your teen’s online activity? Here are points to consider.
  • Teen Privacy: When to Cross the Line Do the dangers of drug abuse override your teen’s right to privacy?
  • Friends: A Bad Influence? 9 Things to Do When You’re Worried
  • 10 Things to Tell Your Teen Real-life advice and how to get through.
  • Preparing Tweens for Middle School Get tips to help your tween cope with this exciting but risky time.

Teens and DXM Drug Abuse

Facts parents and teens need to know.

WebMD Feature Archive

If you’re raising a teenager and you don’t know much about DXM or cough medicine abuse, you’re hardly alone. DXM, or dextromethorphan. is a common ingredient in cough and combination cold medicines. Teens. however, have found another use for cough medicine — getting high. Taking huge doses of cough medicine to get high may sound revolting. In fact, you might assume it’s just an obscure fringe thing.

But it’s not. A 2008 study found that one in 10 American teenagers has abused products with DXM to get high, making it more popular in that age group than cocaine. ecstasy, LSD, and meth. Although DXM products are quite safe when taken as recommended, high doses can cause hallucinogenic trips — and pose serious risks.

DXM is in almost half of all of the OTC drugs sold in the U.S. For teens experimenting with drugs, DXM is cheap, easy to get, and legal.

Surprised? Many parents are.

“A lot of parents just have no idea,” says Deborah Levine MD, clinical assistant professor of pediatrics and emergency medicine at NYU Langone Medical Center. “Alarms would sound if they ever found an empty beer can in a teenager’s car, but they wouldn’t think twice about an empty bottle of cough syrup or used-up package of tablets.”

As a conscientious parent, you may occasionally check the bottles in the liquor cabinet, or sniff for the scent of pot. It’s time to also pay attention to what’s in your medicine cabinet. Here’s what parents need to know about DXM abuse.

Understanding DXM Abuse

DXM – or dextromethorphan – was introduced in the U.S. in the 1950s, and is the most commonly used cough suppressant in the U.S. DXM is now in more than 125 drugs for cough, cold, and flu. including many household names such as Dimetapp DM, Nyquil. Robitussin. Coricidin. Delsym. Theraflu, and Vick’s Formula 44. It’s also used in store brands of cough and cold medicines, such as Wal-Tussin or Wal- Flu sold at Walgreen’s. It’s used in cough syrups, capsules, lozenges, tablets, and gelcaps.


HEALTHY OFFICE – COLD – FLU SEASON – Office Depot Inc #current

#business.officedepot.com

#

HEALTHY OFFICE – COLD FLU SEASON – Office Depot Inc. (www.business.officedepot.com) Kimberley Mules

Financial Fridays: Why Today Is The Day You Have To Reinvent Yourself James Altucher Участник Influencer

End of the line for Priceline s Name Your Own Price airfares George Hobica

Five months into my #Helen4SG campaign Helen Clark Участник Influencer

Ireland appeals $14.5 billion Apple Tax ruling; Gatorade wants a piece of the organic action; And more news John C Abell

Let the Engineers Hire Their Scrum Master Stefan Wolpers

This Week s #Winners and #Losers Ian Bremmer Участник Influencer

Resilience is More Than a Buzzword Diane Regas

Accounting: Making change happen Geni Whitehouse Участник Influencer

Experienced Senior/Major/National Account Manager

HEALTHY OFFICE – COLD FLU SEASON – Office Depot Inc. (www.business.officedepot.com)

16 сент. 2015 г.

  • 96 просмотров

Along with football, cooler temperatures, and the changing of the leaves, Fall means something entirely different: the pending onset of Cold Flu Season. The timing of flu is very unpredictable and can vary in different parts of the country and from season to season. Most seasonal flu activity typically occurs between October and May. Flu activity most commonly peaks in the United States between December and February.

It’s not possible to predict what this flu season will be like. Flu seasons are unpredictable in a number of ways. While flu spreads every year, the timing, severity, and length of the season varies from one year to another. Will new flu viruses circulate this season? Flu viruses are constantly changing so it’s not unusual for new flu viruses to appear each year. For more information about how flu viruses change, visit How the Flu Virus Can Change.

Will the United States have a flu epidemic?

The United States experiences epidemics of seasonal flu each year. This time of year is called “flu season.” In the United States, flu season occurs in the winter; flu outbreaks can happen as early as October and can last as late as May. CDC says the flu season begins when certain key flu indicators (for example, levels of influenza-like illness (ILI), hospitalization and deaths) rise and remain elevated for a number of consecutive weeks. Usually ILI increases first, followed by an increase in hospitalizations, which is then followed by increases in flu-associated deaths.